• PCN200 - COST-OFFSETS ASSOCIATED WITH THE NEW TRIPLETS AVAILABLE FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA AND RESOURCE CONSUMPTION DERIVED FROM ITALIAN REAL PRACTICE

    Oct 1, 2018, 00:00

  • PHP366 - DEVELOPMENT OF THE UNIFIED SYSTEM OF ASSESSMENT OF LEVELS OF EVIDENCE AND GRADES OF RECOMMENDATIONS FOR THE RUSSIAN FEDERATION

    Oct 1, 2018, 00:00

  • PMS36 - SWITCH PATTERNS AND TOTAL HEALTHCARE COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIATIC ARTHRITIS- RESULTS FROM A US CLAIMS ANALYSIS

    Oct 1, 2018, 00:00

  • PHP208 - PHYSICIANS’ IMPROVEMENT SUGGESTIONS FOR ENTERAL NUTRTION CARE IN CHINA- A CROSS-SECTIONAL SURVEY

    Oct 1, 2018, 00:00

  • PMU104 - WHAT ARE THE VIEWS AND PERCEPTIONS OF THE GREEK POPULATION TOWARDS THE PHARMACEUTICAL INDUSTRY?

    Oct 1, 2018, 00:00

  • PMD77 - ECONOMIC EVALUATION OF SCREENING AND PREVENTION STRATEGIES FOR OVARIAN CANCER- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PND28 - A BUDGET IMPACT ANALYSIS OF CLADRIBINE TABLETS VERSUS ALTERNATIVE HIGH EFFICACY TREATMENTS FOR RELAPSING MULTIPLE SCLEROSIS (RMS) IN THE UNITED KINGDOM.

    Oct 1, 2018, 00:00

  • PMD121 - EXPLORING THE DAILY CLINICAL PRACTICE IN MYOCARDIAL INFARCTION (MI) CARE IN EUROPE- SURVEY OF DIAGNOSTIC AND TREATMENT STRATEGIES FOR THEORETICAL PATIENTS

    Oct 1, 2018, 00:00

  • PMH46 - A NATIONAL COMPREHENSIVE SURVEY STUDY OF PARKINSON’S DISEASE PSYCHOSIS PATIENTS AND CAREGIVERS REGARDING TIME TO PARKINSON’S DISEASE PSYCHOSIS DIAGNOSIS AND TREATMENT INITIATION

    Oct 1, 2018, 00:00

  • PHP343 - CLINICAL DEVELOPMENT OF BIOLOGICS APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION, 2003-2016

    Oct 1, 2018, 00:00

  • PMD129 - TRENDS IN OUTCOMES ASSOCIATED WITH ACUTE ISCHEMIC STROKE IN A US COMMERCIAL INSURANCE POPULATION

    Oct 1, 2018, 00:00

  • PND127 - QUALITY OF LIFE IN PAEDIATRIC MULTIPLE SCLEROSIS- SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PCV118 - FACTORS DETERMINING SELECTION OF APPROPRIATE PATIENTS FOR PCSK9 INHIBITORS IN EUROPEAN CLINICAL PRACTICE

    Oct 1, 2018, 00:00

  • PHP28 - EXPLANATIONS FOR THE DIFFERENCES BETWEEN EFFECTS ON ADHERENCE OF VALUE-BASED HEALTH INSURANCE DESIGNS- A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2018, 00:00

  • PHP259 - PHARMACOECONOMIC GUIDELINES RECOMMENDATION FOR TURKEY CONSIDERING REFERENCE COUNTRIES

    Oct 1, 2018, 00:00

  • PIN129 - ADAPTING INFLUENZA PATIENT-REPORTED OUTCOMES (PRO) MEASURES TO MONITOR RESPIRATORY SYNCYTIAL VIRUS (RSV) SYMPTOM SEVERITY IN ADULTS- QUALITATIVE EVIDENCE OF KEY CONCEPTS AND CONTENT VALIDITY

    Oct 1, 2018, 00:00

  • PSY89 - COSTS AND EFFECTS OF ON-DEMAND TREATMENT OF HEREDITARY ANGIOEDEMA- A PROSPECTIVE COHORT STUDY IN ITALY

    Oct 1, 2018, 00:00

  • PIN114 - ASSESSMENT OF THE EFFICACY AND SAFETY OF VORICONAZOLE, COMPARED WITH AVAILABLE THERAPIES IN THE TREATMENT OF PATIENTS WITH INVASIVE ASPERGILLOSIS- A NETWORD META-ANALYSIS

    Oct 1, 2018, 00:00

  • PND156 - THE IMPACT OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) ON WORK- THE PATIENTS’ PERSPECTIVES

    Oct 1, 2018, 00:00

  • PMS78 - CHANGES IN THE PRICES OF INCUMBENT TNF-ALPHA INHIBITORS FOLLOWING THE MARKET ENTRY OF COMPETITORS

    Oct 1, 2018, 00:00

  • PSY104 - CORE OBESITY MODEL TO ASSESS THE COST-EFFECTIVENESS OF WEIGHT MANAGEMENT INTERVENTIONS

    Oct 1, 2018, 00:00

  • PCN130 - COST ASSOCIATED WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) – A RETROSPECTIVE CLAIMS DATA ANALYSIS IN GERMANY

    Oct 1, 2018, 00:00

  • PMD82 - COST-EFFECTIVENESS OF INSULIN PUMP THERAPY IN ADULTS WITH TYPE 1 DIABETES MELLITUS (T1DM)- THE EMIPE STUDY - A REAL-LIFE EVIDENCE STUDY IN FRANCE

    Oct 1, 2018, 00:00

  • PRM28 - PERFORMANCE OF THE EARLY WARNING SYSTEM VITAL TO PREDICT UNANTICIPATED HIGHER-LEVEL OF CARE ADMISSION AND IN-HOSPITAL DEATH OF WARD PATIENTS

    Oct 1, 2018, 00:00

  • PGI21 - COST-EFFECTIVENESS ANALYSIS OF USTEKINUMAB VERSUS ADALIMUMAB, INFLIXIMAB AND VEDOLIZUMAB FOR THE TREATMENT OF PATIENTS WITH MODERATELY TO SEVERE ACTIVE CROHN’S DISEASE FOR TURKEY

    Oct 1, 2018, 00:00

  • PMD78 - COST-EFFECTIVENESS ANALYSIS OF REAL TIME CONTINOUS GLUCOSE MONITORING (RT-CGM) VS SELF MONITORING BLOOD GLUCOSE (SMBG) IN PATIENTS WITH TYPE 1 DIABETES IN SPAIN

    Oct 1, 2018, 00:00

  • PSY6 - EFFECTIVENESS AND SAFETY OF PEGVISOMANT- META-ANALYSIS OF OBSERVATIONAL LONGITUDINAL STUDIES

    Oct 1, 2018, 00:00

  • PRS104 - USING OF "THE FOOD HYPERSENSITIVITY FAMILY IMPACT” (FLIP) QUESTIONNAIRE FOR ASSESSMENT OF QUALITY OF LIFE OF FOOD-ALLERGIC CHILD'S FAMILY MEMBERS.

    Oct 1, 2018, 00:00

  • PCV93 - COST-EFFECTIVENESS OF GUIDELINE ADHERENCE IN CORONARY PATIENTS- THE IMPACT OF THE METHODOLOGY

    Oct 1, 2018, 00:00

  • PCN327 - CHALLENGES AND OPPORTUNITIES IN CLINICAL NUTRITION IN ONCOLOGY- AVAILABLE EVIDENCE, REAL WORLD PRACTICES, AND THE WAY FORWARD

    Oct 1, 2018, 00:00

  • PND105 - MULTIPLE SCLEROSIS- THE MAP OF PATIENT ACCESS TO DISEASE MODIFYING TREATMENTS IN EUROPE

    Oct 1, 2018, 00:00

  • PHP230 - EU5 MARKET ACCESS FOR MEDICINES APPROVED UNDER EXCEPTIONAL CIRCUMSTANCES

    Oct 1, 2018, 00:00

  • PCN297 - IMPACT OF ECONOMIC SANCTIONS ON ACCESS TO NONCOMMUNICABLE DISEASES MEDICINES IN THE ISLAMIC REPUBLIC OF IRAN

    Oct 1, 2018, 00:00

  • PCV10 - RANDOMISED CONTROLLED TRIALS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) – A SYSTEMATIC REVIEW (SR) OF INCLUDED PATIENT POPULATIONS

    Oct 1, 2018, 00:00

  • PCN20 - CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPROVEMENT OF HER2-POSITIVE EARLY BREAST CANCER IN SPAIN

    Oct 1, 2018, 00:00

  • PSS4 - IMPORTANCE OF PROPERLY ADJUSTING FOR HETEROGENEITY AMONG NETWORK META-ANALYSES CONSIDERING OUTCOMES WITH MULTIPLE PRE-DEFINED LEVELS- AN ILLUSTRATIVE EXAMPLE IN PSORIASIS

    Oct 1, 2018, 00:00

  • PSS69 - APPRAISAL OF PATIENT REPORTED OUTCOME INSTRUMENTS IN INFLAMMATORY ACNE

    Oct 1, 2018, 00:00

  • PRM156 - THE IMPORTANCE OF ACCOUNTING FOR PARAMETER UNCERTAINTY AROUND THE SF-6D VALUE SETS AND ITS IMPACT ON STUDIES THAT USE THE SF-6D TO MEASURE HEALTH UTILITY

    Oct 1, 2018, 00:00

  • PCN112 - BURDEN AND COSTS OF ACUTE LYMPHOBLASTIC LEUKAEMIA IN PORTUGAL

    Oct 1, 2018, 00:00

  • PCN383 - ESTIMATING THE HEALTH IMPACT OF INCREASING BREAST AND CERVICAL CANCER SCREENING IN THE NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM AMONG LOW-INCOME WOMEN IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PSY109 - WHAT INTERPRETATION OF ICERS IN ORPHAN DISEASES? A FRENCH EXAMPLE

    Oct 1, 2018, 00:00

  • CE3 - COST-EFFECTIVENESS OF DEMENTIA CARE MANAGEMENT ALONGSIDE A CLUSTER-RANDOMIZED CONTROLLED INTERVENTIONAL DELPHI TRIAL

    Oct 1, 2018, 00:00

  • PCP8 - BENELUXA INITIATIVE- WHY THE FIRST ATTEMPT OF JOINT ASSESSMENT FAILED?

    Oct 1, 2018, 00:00

  • PCN146 - INOTUZUMAB OZOGAMICIN IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LYMPHOCYTIC LEUKEMIA (ALL)- ESTABLISHING A VALUE-BASED COST – PRELIMINARY RESULTS

    Oct 1, 2018, 00:00

  • PRM89 - DATABASE ANALYSIS OF A PSP (PATIENT SUPPORT PROGRAM) FOR PATIENTS USING INTERFERON BETA-1A FOR RELAPSING MULTIPLE SCLEROSIS IN BRAZIL

    Oct 1, 2018, 00:00

  • PCN372 - EVIDENCE MAP OF PATIENT REPORTED OUTCOME STUDIES IN NON-HODGKIN LYMPHOMA SINCE 1960

    Oct 1, 2018, 00:00

  • PHP334 - PHYSICIAN-RELATED FACTORS IN DOCTOR-SHOPPING- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PCN119 - SECONDARY CARE RESOURCE UTILIZATION AND COST OF CARE AMONG FINNISH NON-SMALL CELL LUNG CANCER PATIENTS

    Oct 1, 2018, 00:00

  • PMH35 - ECONOMIC BURDEN OF SCHIZOPHRENIA IN EUROPE

    Oct 1, 2018, 00:00

  • PRM90 - DIGITAL DASHBOARD FOR MAPPING PATIENT DISTRIBUTIONS

    Oct 1, 2018, 00:00

  • PCV7 - COMPARATIVE EFFECTIVENESS OF ORAL PROSTACYCLIN PATHWAY DRUGS ON HOSPITALIZATION AMONG PATIENTS WITH PULMONARY HYPERTENSION- A RETROSPECTIVE ADMINISTRATIVE CLAIMS STUDY IN A MANAGED CARE POPULATION IN THE US

    Oct 1, 2018, 00:00

  • PRM144 - AN OVERVIEW OF META-MODELING METHODS TO ADDRESS RUNTIME ISSUES ASSOCIATED WITH ADVANCED ANALYSES OF HEALTH ECONOMIC MODELS

    Oct 1, 2018, 00:00

  • PSY219 - HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC GRAFT VERSUS HOST DISEASE- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PMU67 - COST-EFFECTIVENESS ANALYSIS OF IXEKIZUMAB VERSUS SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND CONCOMITANT MODERATE-TO-SEVERE PSORIASIS IN THE UNITED KINGDOM

    Oct 1, 2018, 00:00

  • PRS1 - REAL-WORLD EVALUATION OF THE EFFECTIVENESS AND SAFETY OF PIRFENIDONE- FINDINGS FROM AN OBSERVATIONAL CHART REVIEW OF A LARGE COHORT OF IDIOPATHIC PULMONARY FIBROSIS (IPF) PATIENTS IN ITALY

    Oct 1, 2018, 00:00

  • PCN95 - A MULTICENTRIC EVALUATION OF CONSUMABLES AND TRANSPORTS COST OF BREAST CANCER PATIENT’S TREATED BY TRASTUZUMAB ACCORDING TO THE ADMINISTRATION FORM (IV VERSUS SC)

    Oct 1, 2018, 00:00

  • PHP3 - SURVEY OF THE PATIENT ORGANISATION SUBMISSION PROCESS (POSP) TO THE NATIONAL CENTRE FOR PHARMACOECONOMICS (NCPE) IN IRELAND

    Oct 1, 2018, 00:00

  • PMD73 - ECONOMIC IMPACT OF THE TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA ON HIP FRACTURE- A COST-EFFECTIVENESS ANALYSIS

    Oct 1, 2018, 00:00

  • PMU80 - ENHANCING MEDICATION ADHERENCE THROUGH AN ADHERENCE SUPPORT PROGRAM

    Oct 1, 2018, 00:00

  • PMS35 - COSTS AND HEALTH SERVICE USE ASSOCIATED WITH FLUOROQUINOLONE-RELATED TENDON INJURIES

    Oct 1, 2018, 00:00

  • PRM86 - INFLAMMATORY BOWEL DISEASE AND THE COST FOR SOCIAL SECURITY SYSTEM- ESTIMATING THE PREVALENCE AND THE DISABILITY BURDEN AMONG THE ITALIAN WORKER

    Oct 1, 2018, 00:00

  • PIN81 - PHARMACISTS AS VACCINATORS- FIRST YEAR EXPERIMENTATION ON SEASONAL INFLUENZA VACCINATION IN FRANCE

    Oct 1, 2018, 00:00

  • PSY117 - ASSESSMENT OF SOCIAL AND ECONOMIC BURDEN OF CHRONIC MYELOID LEUKEMIA IN BULGARIA

    Oct 1, 2018, 00:00

  • PMU109 - CONTINGENT VALUATION STUDY TO QUANTIFY THE VALUE PLACED ON THICKENERS IN THE MANAGEMENT OF DYSPHAGIA

    Oct 1, 2018, 00:00

  • PHP256 - MACHINE LEARNING TO IDENTIFY REAL-WORLD PATIENT CHARACTERISTICS ASSOCIATED WITH LENGTH OF HOSPITALIZATION

    Oct 1, 2018, 00:00

  • DS2 - EFFECTIVENESS AND SAFETY OF STANDARD AND REDUCED DOSES OF DABIGATRAN VERSUS RIVAROXABAN IN NON-VALVULAR ATRIAL FIBRILLATION- A COHORT STUDY IN THE SNDS FRENCH NATIONWIDE CLAIMS DATABASE

    Oct 1, 2018, 00:00

  • MO1 - COMBINING INTERNALLY VALID TRIAL EVIDENCE WITH GENERALIZABLE REAL-WORLD DATA- INSIGHTS INTO EFFECTS, COSTS, AND COST-EFFECTIVENESS OF NOVEL TREATMENT SEQUENCES IN PATIENTS WITH MULTIPLE MYELOMA

    Oct 1, 2018, 00:00

  • PRM218 - CHARACTERISING AND APPRAISING PATIENT PREFERENCE EXPLORATION AND ELICITIATION METHODS IN THE MEDICAL PRODUCT LIFECYCLE

    Oct 1, 2018, 00:00

  • PGI43 - WHAT DO PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) VALUE AND NEED? RESULTS FROM A QUANTITATIVE PATIENT PREFERENCE STUDY

    Oct 1, 2018, 00:00

  • PCN22 - MARKETING AUTHORISATION PRACTICE OF THE EUROPEAN MEDICINES AGENCY (EMA) IN ONCOLOGICAL INDICATIONS

    Oct 1, 2018, 00:00

  • PIN49 - THE COST-EFFECTIVENESS ANALYSIS OF ANIDULAFUNGIN VERSUS CASPOFUNGIN FOR CANDIDEMIA AND INVASIVE CANDIDIASIS TREATMENT- AN EXPERIENCE FROM IRAN

    Oct 1, 2018, 00:00

  • PSY73 - ECONOMIC AND SOCIAL BURDEN OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA- A SYSTEMATIC REVIEW OF THE LITERATURE

    Oct 1, 2018, 00:00

  • PMU100 - MAPPING BENEFIT-RISK DECISION-MAKING PROCESSES AND IDENTIFYING DECISION POINTS WITH THE POTENTIAL TO INCLUDE PATIENT PREFERENCE INFORMATION THROUGHOUT THE MEDICAL PRODUCT LIFECYCLE

    Oct 1, 2018, 00:00

  • PHP327 - CATEGORISATION OF OBSERVATIONAL STUDIES REQUESTED BY THE EMA AND SUBMITTED TO THE EUROPEAN UNION (EU) ELECTRONIC REGISTER OF POST-AUTHORIZATION STUDIES (PAS)

    Oct 1, 2018, 00:00

  • PRS81 - PRESCRIBING PATTERN AND USE OF STEROIDS AMONG ASTHMATIC PATIENTS IN A TERTIARY CARE HOSPITAL

    Oct 1, 2018, 00:00

  • PCP37 - THE CONFIDENTIALITY REGARDING DRUGS PRICING AND REIMBURSEMENT IN ROMANIA

    Oct 1, 2018, 00:00

  • PCN179 - THE COMPARATIVE PHARMACOECONOMIC ANALYSIS OF USING DIFFERENT ERYTHROPOIESIS-STIMULANTIG AGENTS FOR MANAGING CHEMOTHERAPY-INDUCED ANEMIA IN ADULT CANCER PATIENTS IN ACTUAL PRACTICE IN RUSSIA

    Oct 1, 2018, 00:00

  • PSY12 - REAL-WORLD EFFECTIVENESS STUDY OF FERRIC CARBOXYMALTOSE IN ANAEMIC PATIENTS

    Oct 1, 2018, 00:00

  • PND137 - PATTERNS OF USE OF PROLONGED-RELEASE FAMPRIDINE AND PHYSIOTHERAPY AMONG PATIENTS WITH MS IN TWO LARGE MULTI-COUNTRY STUDY COHORTS

    Oct 1, 2018, 00:00

  • PND90 - THE IMPACT OF MINISTRY OF FOOD AND DRUG SAFETY (MFDS) SAFETY NOTICE ON THE USE OF METOCLOPRAMIDE IN KOREA- A POPULATION-BASED STUDY WITH AN INTERRUPTED TIME SERIES ANALYSIS

    Oct 1, 2018, 00:00

  • PMD67 - COST-CONSEQUENCE ANALYSIS OF A HEMOSTATIC FLOWABLE MATRIX ALONE OR IN COMBINATION FOR SPINE SURGERY PATIENTS

    Oct 1, 2018, 00:00

  • PCN230 - ARE NICE AND THE SMC DIVERGING IN THEIR ASSESSMENT OF ONCOLOGY DRUGS?

    Oct 1, 2018, 00:00

  • PSY211 - THE CLINICAL, HUMANISTIC, AND ECONOMIC BURDEN OF ADENOSINE DEAMINASE (ADA) SEVERE COMBINED IMMUNODEFICIENCY (SCID)- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PSY30 - INCIDENCE AND PREVALENCE OF NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE IN US MEDICARE, 2008-2015

    Oct 1, 2018, 00:00

  • PCN27 - THE REAL-WORLD COST AND EFFECTIVENESS OF EVEROLIMUS IN METASTATIC BREAST CANCER IN THE CZECH REPUBLIC

    Oct 1, 2018, 00:00

  • PND149 - FACTORS ASSOCIATED WITH THE CAREGIVERS’ INTENTION TO INSTITUTIONALIZE PERSONS WITH DEMENTIA

    Oct 1, 2018, 00:00

  • PHP332 - INTRODUCTION OF MOBILE HEALTH TECHNOLOGY AT THE PRIMARY HEALTHCARE LEVEL IN MONGOLIA

    Oct 1, 2018, 00:00

  • PRM250 - THE ANALYSIS OF ONCOLOGICAL PATIENT DETECTION IN MOSCOW

    Oct 1, 2018, 00:00

  • PCN57 - THE ASSOCIATION BETWEEN METFORMIN EXPOSURE AND SURVIVAL AMONG DIABETIC PATIENTS WITH NON-SMALL CELL LUNG CANCER

    Oct 1, 2018, 00:00

  • PMD56 - COST OF STENT-RETRIEVER MECHANICAL THROMBECTOMY IN PATIENTS WITH ISCHEMIC STROKE IN THE RUSSIAN FEDERATION

    Oct 1, 2018, 00:00

  • PHP337 - OFF-LABEL PRESCRIPTION OF DRUGS COMPARED TO PRESCRIPTION AFTER LABEL EXTENSION IN CHILDREN FOR GERMANY

    Oct 1, 2018, 00:00

  • PCP49 - EXPLORING THE SENSITIVITY TO CHANGE OF THE SAMANTA QUESTIONNAIRE IN HEAVY MENSTRUAL BLEEDING- THE SAMIRA STUDY

    Oct 1, 2018, 00:00

  • PMD109 - A CANADIAN COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IMPLANTED AT TIME OF CATARACT SURGERY IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA

    Oct 1, 2018, 00:00

  • PDB39 - EMPAGLIFLOZIN FOR PATIENTS IN THE NETHERLANDS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED CARDIOVASCULAR DISEASE- A BUDGET IMPACT MODEL

    Oct 1, 2018, 00:00

  • PRM24 - A JOINT MODEL OF COGNITIVE DECLINE AND TIME TO DIAGNOSIS TO IMPROVE PREDICTIONS OF THE RISK OF DEVELOPING ALZHEIMER’S DISEASE

    Oct 1, 2018, 00:00

  • PHP184 - PATIENT INFLUENCE ON BIOSIMILAR UPTAKE- THE NOCEBO EFFECT

    Oct 1, 2018, 00:00

  • PHP229 - EU5 MARKET ACCESS FOR MEDICINES WITH CONDITIONAL MARKETING AUTHORISATIONS

    Oct 1, 2018, 00:00

  • PSY79 - THE COST OF MAJOR BLEEDING EVENTS ASSOCIATED WITH ANTICOAGULATION TREATMENT – AN ESTIMATION OF THE CONTRIBUTION OF THE REVERSAL AGENTS TO THE OVERALL COST OF MAJOR BLEEDING IN A UK SETTING

    Oct 1, 2018, 00:00

  • PCN286 - INCREMENTAL COST-EFFECTIVENESS RATIO FOR THE ANTINEOPLASTIC DRUGS APPROVED AND REJECTED FOR THE VITAL AND ESSENTIAL DRUGS LIST IN 2017 IN RUSSIA

    Oct 1, 2018, 00:00

  • PCN136 - A COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN CANADA

    Oct 1, 2018, 00:00

  • PIN27 - COMMUNITY-ACQUIRED PNEUMONIA HOSPITALIZATION COSTS IN THE ADULT POPULATION OF COSTA RICA FROM A PUBLIC HEALTH PERSPECTIVE OVER A 10 YEAR PERIOD (2005-2014)

    Oct 1, 2018, 00:00

  • PSS53 - ORIGINATOR AND GENERIC MARKET ACCESS PROTECTION STRATEGIES IN GERMANY USING DERMATOLOGY AS AN EXAMPLE

    Oct 1, 2018, 00:00

  • PCN277 - PREDICTORS OF HOSPITALIZATIONS AND EMERGENCY DEPARTMENT (ED) VISITS IN SECOND-LINE (2L) ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC)

    Oct 1, 2018, 00:00

  • PHP113 - COMPARATIVE ANALYSIS OF BIOSIMILAR RITUXIMAB USAGE IN TREATING NON-HODGKIN LYMPHOMA AND RHEUMATOID ARTHRITIS- RESULTS FROM A MULTI-COUNTRY STUDY IN EUROPE

    Oct 1, 2018, 00:00

  • PCN175 - BRENTUXIMAB VEDOTIN COMPARED WITH STANDARD THERAPY FOR PATIENTS WITH ADVANCED-STAGE HODGKIN’S LYMPHOMA- A COST-EFFECTIVENESS ANALYSIS

    Oct 1, 2018, 00:00

  • PMS93 - ASSESSMENT OF PATIENTS’ ADHERENCE ON MTX USE- A PATIENT ASSOCIATION SURVEY.

    Oct 1, 2018, 00:00

  • PMU97 - OLDER ADULTS SATISFACTION WITH PHARMACEUTICAL CARE IN AN OUTPATIENT PHARMACY OF A NIGERIAN TEACHING HOSPITAL

    Oct 1, 2018, 00:00

  • PRM252 - SIMULATED TREATMENT COMPARISON- IMPLICATIONS AND CHALLENGES OF AN ALTERNATIVE APPROACH TO ESTIMATING THE RELATIVE EFFICACY OF NIVOLUMAB VERSUS RELEVANT COMPARATOR CHEMOTHERAPY TREATMENTS FOR ADVANCED/METASTATIC UROTHELIAL CARCINOMA ...

    Oct 1, 2018, 00:00

  • PHP239 - THE INTRODUCTION AND IMPLICATIONS OF THE COST-CONTAINMENT MEASURE ‘THE SLUICE’ FOR EXPENSIVE INNOVATIVE DRUGS IN THE NETHERLANDS

    Oct 1, 2018, 00:00

  • PRM108 - EVALUATION OF CATARACT TREATMENT IN THE UNITED KINGDOM USING A PATIENT PATHWAY DISCREET EVENT SIMULATION MODEL

    Oct 1, 2018, 00:00

  • PCN17 - INDIRECT TREATMENT COMPARISONS OF NIVOLUMAB VERSUS REGORAFENIB, CABOZANTINIB AND BEST SUPPORTIVE CARE AFTER TREATMENT WITH SORAFENIB FOR HEPATOCELLULAR CARCINOMA

    Oct 1, 2018, 00:00

  • PRS90 - ASSOCIATION BETWEEN SEVERE, MODERATE AND MILD EXACERBATIONS WITH GENERIC HEALTH-RELATED QUALITY OF LIFE IN COPD PATIENTS

    Oct 1, 2018, 00:00

  • PCN173 - COST-EFFECTIVENESS OF NEW TRIPLET COMBINATIONS WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

    Oct 1, 2018, 00:00

  • PND89 - BLOOD LOSS AND TRANSFUSION MANAGEMENT IN COMPLEX MULTI-LEVEL SPINE SURGERY IN EUROPE

    Oct 1, 2018, 00:00

  • PP1 - CONSIDERATIONS FOR USING A WEB-BASED SYSTEM TO COLLECT PATIENT-REPORTED OUTCOME (PRO) DATA

    Oct 1, 2018, 00:00

  • PCN150 - COST-EFFECTIVENESS ANALYSIS OF PHARMACOKINETIC-GUIDED (PK) 5-FLUOROURACIL (5-FU) DOSING WHEN COMBINED WITH LEUCOVORIN, IRINOTECAN AND OXALIPLATIN (FOLFIRINOX) CHEMOTHERAPY FOR ADVANCED PANCREAS CANCER

    Oct 1, 2018, 00:00

  • PMS64 - MULTIPLE SCLEROSIS AND WORKABILITY IN ITALY- THE ECONOMIC EFFECT OF NATALIZUMAB ON THE ABILITY TO WORK

    Oct 1, 2018, 00:00

  • PMS117 - A MULTIDSCIPLINARY STUDY ON HEALTH-RELATED QUALITY OF LIFE IN CLUBFOOT

    Oct 1, 2018, 00:00

  • PIN99 - DOES A CHANGE IN VACCINATION SCHEME AFFECT PNEUMOCOCCAL CONJUGATE VACCINATION ADHERENCE? COMPARISON OF QUOTAS AND ADHERENCE IN MATURE BORN INFANTS IN GERMANY

    Oct 1, 2018, 00:00

  • PUK24 - HYPERKALAEMIA IN CHRONIC KIDNEY DISEASE- PATIENT TREATMENT EXPERIENCE WITH RENIN-ANGIOTENSIN-ALDOSTERONE- SYSTEM INHIBITORS IN PRIMARY CARE IN ENGLAND

    Oct 1, 2018, 00:00

  • PSY45 - BUDGET IMPACT ANALYSIS OF THE PATIENT BLOOD MANAGEMENT FROM A FRENCH NATIONAL PAYER AND HOSPITAL PERSPECTIVES IN FRANCE

    Oct 1, 2018, 00:00

  • PMU49 - HEALTH INSURANCE COST OF PSORIASIS IN HUNGARY- COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2018, 00:00

  • PDB46 - CLINICAL AND ECONOMIC BURDEN OF TYPE 1 DIABETES IN REAL-LIFE SETTING IN SPAIN

    Oct 1, 2018, 00:00

  • PSY123 - IDENTIFICATION OF THE TREATMENT ATTRIBUTES TO BE CONSIDERED IN SHARED DECISION MAKING FOR ANKYLOSING SPONDYLITIS PATIENTS- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PRM266 - 50 MILLION TESTS AND CONFOUNDING- THE PROMISES AND CHALLENGES OF BIG DATA

    Oct 1, 2018, 00:00

  • PRM211 - MITIGATING EMOTIONAL BURDEN OF CONDUCTING INTERVIEWS WITH PEDIATRIC PATIENTS AND/OR THEIR CAREGIVERS ON THE INTERVIEWER- FIRST-PERSON INTERVIEWER EXPERIENCES

    Oct 1, 2018, 00:00

  • PDB43 - THE COSTS AND RESULTS OF INCRETINS’AND SGLT-2I DIABETES THERAPY IN BULGARIA

    Oct 1, 2018, 00:00

  • PRM247 - META-ANALYSES USING REAL-WORLD DATA- A SYSTEMATIC LITERATURE REVIEW OF EXISTING RECOMMENDATIONS

    Oct 1, 2018, 00:00

  • PCN347 - EXPLORING THE IMPACT OF RADIOGRAPHIC PROGRESSIVE DISEASE AND FIRST SUBSEQUENT THERAPY ON HEALTH STATE UTILITY VALUES IN GERMLINE-BRCA-MUTATED (GBRCAM) PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER (PSROC) PATIENTS ON OLAPARIB TABLETS ...

    Oct 1, 2018, 00:00

  • PHP215 - DANISH MEDICINE COUNCIL PROCESS OF ASSESSING NEW HOSPITAL MEDICINES– FIRST YEAR OF IMPLEMENTATION

    Oct 1, 2018, 00:00

  • PND139 - IMPACT OF PROLONGED-RELEASE FAMPRIDINE ON FATIGUE AMONG PEOPLE WITH MULTIPLE SCLEROSIS IN A MULTI-COUNTRY STUDY

    Oct 1, 2018, 00:00

  • PCN60 - REAL-WORLD OVERALL SURVIVAL OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER- RESULTS OF A CLAIMS DATA STUDY OF PATIENTS IN GERMANY

    Oct 1, 2018, 00:00

  • PCN59 - ASSOCIATION BETWEEN HAZARD RATIOS OF SURROGATE TIME-TO-EVENT ENDPOINTS AND OVERALL SURVIVAL IN ADVANCED/METASTATIC CANCERS

    Oct 1, 2018, 00:00

  • PCV151 - WHAT ARE THE MOST VALUED PATIENT OUTCOMES REGARDING MEDICAL CARE FOR FRENCH PATIENTS WITH HEART FAILURE? RESULTS FROM AN ONLINE PATIENT COMMUNITY (CARENITY.COM)

    Oct 1, 2018, 00:00

  • PHP231 - ADOPTION OF INNOVATIONS IN THE GERMAN DRG-SYSTEM – A QUANTITATIVE ANALYSIS

    Oct 1, 2018, 00:00

  • PMS116 - HUMANISTIC AND ECONOMIC BURDEN OF X-LINKED HYPOPHOSPHATEMIA (XLH)- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PMU54 - HOW MUCH DOES IT COST TO TRAIN A PHYSICIAN IN COLOMBIA?

    Oct 1, 2018, 00:00

  • PMS95 - DO DISAGREEMENTS BETWEEN PATIENT AND POPULATION VALUATIONS DIFFER BY SOCIO-DEMOGRAPHIC GROUP AND/OR HEALTH STATUS? AN EXPLORATORY STUDY AMONG CHRONIC LOW BACK PAIN PATIENTS

    Oct 1, 2018, 00:00

  • PMS44 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB PLUS METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT

    Oct 1, 2018, 00:00

  • PHP356 - COMPARATIVE ANALYSIS BETWEEN OLD AND NEW ITALIAN INNOVATION RATING SYSTEM

    Oct 1, 2018, 00:00

  • PRM245 - EXTRAPOLATION OF SURVIVAL IN THE CONTEXT OF ECONOMIC MODELLING USING BAYESIAN MODEL AVERAGING- AN APPLICATION IN RENAL CELL CARCINOMA

    Oct 1, 2018, 00:00

  • PRM147 - OPEN-SOURCE MODELS IN HEALTH ECONOMICS- EXPERIENCE BASED ON A DISCRETE EVENT SIMULATION MODEL IN MAJOR DEPRESSIVE DISORDER

    Oct 1, 2018, 00:00

  • PCV119 - BASELINE HEALTH RELATED QUALITY OF LIFE IN PATIENTS ADMITTED BY HEART FAILURE. DOES GENDER MATTER?

    Oct 1, 2018, 00:00

  • PIN48 - COST-EFFECTIVENESS ANALYSIS OF ANIDULAFUNGIN FOR THE MANAGEMENT OF INVASIVE CANDIDIASIS IN COLOMBIAN ADULTS

    Oct 1, 2018, 00:00

  • PSY125 - PHYSICIANS' AND PHARMACISTS’ PRIORITIES IN TREATMENT DECISION-MAKING FOR CHRONIC LYMPHOCYTIC LEUKEMIA

    Oct 1, 2018, 00:00

  • PMD79 - COST-EFFECTIVENESS OF ULTRASOUND-GUIDED CENTRAL VENOUS CATHETERISATION FROM THE GERMAN PAYER PERSPECTIVE.

    Oct 1, 2018, 00:00

  • PMS112 - PATIENT AND RHEUMATOLOGIST PREFERENCES FOR THE ATTRIBUTES OF RHEUMATOID ARTHRITIS TREATMENTS IN SPAIN. A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2018, 00:00

  • PCN265 - END OF LIFE CANCER CHEMOTHERAPY- A RETROSPECTIVE STUDY DURING INTENSIVE CARE UNIT (ICU) STAY

    Oct 1, 2018, 00:00

  • PRS101 - IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ON QUALITY OF LIFE- FINDINGS FROM A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PRM19 - REPORTING FOLLOW-UP IN SURVIVAL ANALYSES- INFORMATIVE OR NOT?

    Oct 1, 2018, 00:00

  • PMS109 - PREVENTION OF SHOULDER JOINT INJURIES IN WATER POLO WITH STRETCHING AND STABILIZATION TECHNIQUES

    Oct 1, 2018, 00:00

  • Vaccination Programs- Economic and Leadership Considerations

    Oct 1, 2018, 00:00

  • PSY86 - HIGHER LEVELS OF SKIN CLEARANCE ARE ASSOCIATED WITH DECREASED INDIRECT COSTS RELATED TO PRODUCTIVITY LOSS IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS

    Oct 1, 2018, 00:00

  • PRS61 - ASSESSMENT OF ASTHMA-DIAGNOSED POPULATION ELIGIBLE FOR NEW MONOCLONAL ANTIBODY THERAPY IN VENETO REGION

    Oct 1, 2018, 00:00

  • PRM16 - AN ESTIMATED GLOMERULAR FILTRATION RATE (EGFR) LEVEL PREDICTION IN POPULATION-BASED ADMINISTRATIVE DATABASES IN THE ABSENCE OF RECORDED LABORATORY VALUES

    Oct 1, 2018, 00:00

  • PSY163 - IDENTIFICATION OF KEY ORPHAN DRUG ATTRIBUTES IN PREDICTING THE EXPECTED LEVEL OF PAYER MANAGEMENT IN THE US AND EU3

    Oct 1, 2018, 00:00

  • PND102 - CARE PATHWAY DIVERSITY OF PATIENTS WITH MULTIPLE SCLEROSIS BETWEEN FRENCH REGIONS

    Oct 1, 2018, 00:00

  • PIH13 - ABIRATERONE- A SINGLE-CENTRE EXPERIENCE

    Oct 1, 2018, 00:00

  • PND86 - ECONOMIC BENEFITS ON ADULT UPPER LIMB SPASTICITY TREATMENT WITH ABOBOTULINUMTOXIN-A COMPARED TO ONABOTULINUMTOXIN-A OR INCOBOTULINUMTOXIN-A- ANALYSES IN A REAL-LIFE SETTING IN FRANCE

    Oct 1, 2018, 00:00

  • PRM74 - CLINICAL OUTCOME ASSESSMENTS IN DRUG APPROVALS- A REVIEW OF LABEL CLAIMS IN THE UNITED STATES AND EUROPE (2013-2017)

    Oct 1, 2018, 00:00

  • PIH28 - ISAACUS DATA LAKE PRE-PRODUCTION PROJECT- CHILD PLACEMENT DECISION AND ITS COST DRIVERS

    Oct 1, 2018, 00:00

  • PCN54 - IN-HOSPITAL RESOURCE USE FOR CANCER IN GERMANY FROM 2010 TO 2015

    Oct 1, 2018, 00:00

  • PSS62 - TREATMENT PREFERENCE DRIVERS OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

    Oct 1, 2018, 00:00

  • PSS10 - QUANTITATIVE ANALYSIS OF DIABETIC RETINOPATHY (DR) IN THE UK USING ROUTINELY COLLECTED DATA FROM SCREENING PROGRAMME AND HOSPITAL EYE SERVICE (HES) DATABASES

    Oct 1, 2018, 00:00

  • PCN113 - EVALUATING THE ECONOMIC IMPACT OF NOVEL AGENTS FOR TREATING MULTIPLE MYELOMA

    Oct 1, 2018, 00:00

  • PRM248 - REFERENCED-BASED IMPUTATION FOR THE COST-EFFECTIVENESS ANALYSIS OF LONGITUDINAL RANDOMISED TRIAL

    Oct 1, 2018, 00:00

  • PMS75 - SEEKING THE STATE OF THE ART IN STANDARDIZED MEASUREMENT OF HEALTH CARE RESOURCE USE AND COSTS IN JUVENILE IDIOPATHIC ARTHRITIS- A SCOPING REVIEW

    Oct 1, 2018, 00:00

  • PGI42 - NON-PERSISTENCE WITH IMMUNOSUPPRESANT, ANTI-TUMOR NECROSIS FACTOR, AND ANTI-INTEGRIN AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE- A RETROSPECTIVE CLAIMS DATA ANALYSIS IN GERMANY

    Oct 1, 2018, 00:00

  • PMH78 - CARE BURDEN AND QUALITY OF LIFE OF PRIMARY CAREGIVERS OF CHILDREN WITH INTELLECTUAL DISABILITIES IN MONGOLIA- THE MEDIATING EFFECT OF FAMILY STRENGTH

    Oct 1, 2018, 00:00

  • PHP146 - ANALYSES OF THE PERFORMANCE INDICATORS OF REHABILITATION AND CHRONIC INPATIENT CARE IN HUNGARY BETWEEN 1990 AND 2016

    Oct 1, 2018, 00:00

  • PHP219 - MEDICINRÅDET AND THE NEW HOSPITAL DRUG APPRAISAL PROCESS IN DENMARK – THE STORY SO FAR

    Oct 1, 2018, 00:00

  • PCN168 - COST-EFFECTIVENESS OF SORAFENIB IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PIH50 - RESILIENCE AND ITS INFLUENCING FACTORS’ EFFECT ON TIMELY APPEARENCE OF 2ND AND 3RD PHASE OF LACTOGENESIS

    Oct 1, 2018, 00:00

  • PCN68 - BUDGET IMPACT ANALYSIS OF TISAGENLECLEUCEL FOR THE TREATMENT OF PAEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA IN ENGLAND

    Oct 1, 2018, 00:00

  • PND140 - IMPACT OF MIGRAINE ON WORK PRODUCTIVITY IN PORTUGUESE PATIENTS

    Oct 1, 2018, 00:00

  • PMU16 - DISPENSING PATTERNS OF VACCINES IN A PRIVATE HEALTHCARE SETTING IN SOUTH AFRICA

    Oct 1, 2018, 00:00

  • PCV111 - CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS AMONG PATIENTS WITH VENOUS THROMBOEMBOLISM PRESCRIBED ANTICOAGULANTS IN GERMANY

    Oct 1, 2018, 00:00

  • PIN105 - THE PUBLIC HEALTH IMPACT OF TICK-BORNE ENCEPHALITIS VACCINATION ON THE SLOVENIAN ADULT POPULATION

    Oct 1, 2018, 00:00

  • PHP115 - COMPARATIVE ANALYSIS OF THE MARKET PENETRATION OF PERSONALISED MEDICINE DRUGS UNDER THE CONDITIONS OF AMNOG

    Oct 1, 2018, 00:00

  • PMD139 - VALUE-BASED PROCUREMENT OF MEDICAL EQUIPMENT IN EUROPE – DID THE 2014 EU DIRECTIVE INFLUENCE TENDERING PRACTICES AND EVIDENCE DEMAND?

    Oct 1, 2018, 00:00

  • PDB119 - PATIENT PREFERENCES AND HEALTH STATE UTILITIES ASSOCIATED WITH MEALTIME INSULIN CONCENTRATIONS AMONG PATIENTS WITH DIABETES IN ITALY

    Oct 1, 2018, 00:00

  • PCV11 - MODELING CARDIOVASCULAR EVENT REDUCTION THROUGH LOW-DENSITY LIPOPROTEIN REDUCTION IN COST-EFFECTIVENESS ANALYSES- A META-REGRESSION APPROACH

    Oct 1, 2018, 00:00

  • PMD41 - THE BUDGET IMPACT AND COST-CONSEQUENCE OF TREATING DIABETIC FOOT ULCERS WITH URGOSTART

    Oct 1, 2018, 00:00

  • Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination- A Systematic Review of the Literature

    Oct 1, 2018, 00:00

  • PCN97 - ASSESSING THE IMPACT OF ACTIVE IDENTIFICATION OF PATIENTS APPROPRIATE FOR PALLIATIVE CARE ON RESOURCE UTILIZATION AND COSTS IN THE FINAL MONTH OF LIFE

    Oct 1, 2018, 00:00

  • PHP126 - SCARS OF CHILD POVERTY IN ADULTS- A HEALTH PERSPECTIVE

    Oct 1, 2018, 00:00

  • PND63 - COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN

    Oct 1, 2018, 00:00

  • PDB57 - TRENDS IN USE OF DRUGS FOR DIABETES TREATMENT IN SLOVAKIA- REVIEW OF CONSUMPTION DATA FROM 2007 TILL 2017

    Oct 1, 2018, 00:00

  • PCN300 - MODERN TRENDS OF ORCHIECTOMY FOR PROSTATE CANCER

    Oct 1, 2018, 00:00

  • PDB81 - DAPAGLIFLOZIN IS COST-EFFECTIVE COMPARED TO DPP-4 INHIBITORS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN THE NETHERLANDS

    Oct 1, 2018, 00:00

  • PHP275 - ORPHAN MEDICINAL PRODUCTS GIVEN AN INITIAL NEGATIVE RECOMMENDATION BY NICE'S STA PROCESS BUT APPROVED FOLLOWING RE-EVALUATION IN ENGLAND

    Oct 1, 2018, 00:00

  • PRS72 - A COST ESTIMATION OF MANAGEMENT OF ALLERGIC ASTHMA IN ITALY

    Oct 1, 2018, 00:00

  • PMS16 - EFFECT OF BISPHOSPHONATES ON PERIPROSTHETIC BONE MINERAL DENSITY LOSS AFTER HIP ARTHROPLASTY- AN INDIRECT TREATMENT COMPARISON OF RANDOMIZED CONTROLLED TRIALS

    Oct 1, 2018, 00:00

  • PRM187 - A SYSTEMATIC REVIEW OF UTILITY ESTIMATES IN MELANOMA IN THE ADJUVANT SETTING

    Oct 1, 2018, 00:00

  • PIN68 - COST-EFFECTIVENESS ANALYSIS OF ISAVUCONAZOLE FOR THE TREATMENT OF INVASIVE ASPERGILLOSIS IN THE CZECH REPUBLIC

    Oct 1, 2018, 00:00

  • PCN98 - PALLIATIVE TREATMENT AND ITS COST IN THE LAST SIX MONTHS OF LIFE FOR METASTATIC COLORECTAL CANCER PATIENTS

    Oct 1, 2018, 00:00

  • PSY136 - A COMPARISON OF PR REQUIREMENTS FOR ORPHAN DRUGS IN 25 MARKETS

    Oct 1, 2018, 00:00

  • PSY14 - CLINICAL RESPONSE TO SYSTEMIC TREATMENTS FOR STEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PSS17 - COST PER RESPONDER ANALYSIS OF BRODALUMAB COMPARED WITH USTEKINUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN CANADA

    Oct 1, 2018, 00:00

  • PRS62 - PHARMACIST-LED SMOKING CESSATION SERVICES IN RESOURCE LIMITED SETTINGS- A CROSS-SECTIONAL AND SIMULATED STUDY IN ETHIOPIA

    Oct 1, 2018, 00:00

  • PND50 - SOCIAL RETURN ON INVESTMENT OF AN IDEAL APPROACH TO MULTIPLE SCLEROSIS WITHIN THE SPANISH NATIONAL HEALTH SYSTEM

    Oct 1, 2018, 00:00

  • PRM139 - CHOOSING THE RIGHT SOFTWARE FOR HTA ECONOMIC MODELS- A COMPARISON OF FOUR PROGRAMMES RECOMMENDED BY THE NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE

    Oct 1, 2018, 00:00

  • PIN128 - INSUFFICIENT DECLINE IN HIV PREVALENCE AMIDST HIGH SCORES IN HIV TESTING AND AWARENESS- A LOGISTIC MODELLING FOR HIV PREVALENCE INFORMATION AND INDIVIDUAL PROTECTIVE BEHAVIOURS IN UGANDA

    Oct 1, 2018, 00:00

  • PRM251 - EVALUATING BUDGET IMPACT OF CURES. MACHINE LEARNING METHODS SHED LIGHT ON WHO CAN BE CURED IN METASTATIC MELANOMA

    Oct 1, 2018, 00:00

  • PCN364 - EVALUATING PSYCHOMETRIC PROPERTIES OF UK EQ-5D-5L SCORING ALGORITHMS IN METASTATIC MERKEL CELL CARCINOMA

    Oct 1, 2018, 00:00

  • PND20 - INCIDENCE AND TREATMENT OF PATIENTS WITH STATUS EPILEPTICUS- AN ANALYSIS OF GERMAN CLAIMS DATA

    Oct 1, 2018, 00:00

  • PMS68 - HOSPITAL PHARMACY CENTRALIZED PROCESS FOR HOSPITAL-WIDE MANAGEMENT OF BIOSSIMILARS USE AND ITS EFFICIENCY

    Oct 1, 2018, 00:00

  • PMD145 - CHARACTERIZING BURDEN OF INTRAOPERATIVE AND EARLY POSTOPERATIVE PERIPROSTHETIC HIP FRACTURES FOLLOWING TOTAL HIP ARTHROPLASTY

    Oct 1, 2018, 00:00

  • PMS96 - A DEMAND SURVEY ON PATIENT EDUCATION FOR PATIENTS WITH RHEUMATOID ARTHRITIS

    Oct 1, 2018, 00:00

  • PDB53 - EVALUATING THE RELATIONSHIP BETWEEN GLYCEMIC CONTROL, INCIDENCE OF SEVERE HYPOGLYCEMIA, AND LONG-TERM HEALTH ECONOMIC OUTCOMES IN PATIENTS WITH TYPE 1 DIABETES IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PUK21 - COST UTILITY ANALYSIS OF END STAGE RENAL DISEASE TREATMENT IN MINISTRY OF HEALTH DIALYSIS CENTRES, MALAYSIA- HAEMODIALYSIS VERSUS CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

    Oct 1, 2018, 00:00

  • PRM56 - COULD ERG PREFERENCES FOR DIFFERENT OVERALL SURVIVAL EXTRAPOLATION METHODOLOGIES DRIVE DIFFERENT NICE APPRAISAL OUTCOMES?

    Oct 1, 2018, 00:00

  • PCN293 - WHAT IS THE VALUE OF REAL WORLD EVIDENCE IN ONCOLOGY IN HTA APPRAISALS IN ENGLAND, FRANCE, CANADA AND AUSTRALIA?

    Oct 1, 2018, 00:00

  • PHP317 - IDENTIFYING THE CHANGES REQUIRED IN HEALTH TECHNOLOGY ASSESSMENT SYSTEMS IF OUTCOMES ARE TO BE OPTIMIZED IN A DIGITAL WORLD WHERE PERSONALIZED DATA AND PRECISION MEDICINE COLLIDE

    Oct 1, 2018, 00:00

  • PRM13 - THE FLAWED RECOMMENDATIONS OF THE SECOND PANEL ON COST-EFFECTIVENESS IN HEALTH AND MEDICINE

    Oct 1, 2018, 00:00

  • CN3 - VALUE OF ADJUVANT ONCOLOGY THERAPIES- METHODOLOGICAL CHALLENGES OF MODELLING COST-EFFECTIVENESS OF AN ADJUVANT TREATMENT IN AN ERA OF HIGH-COST ONCOLOGY TREATMENTS

    Oct 1, 2018, 00:00

  • PRS16 - MODELED SURVIVAL GAINS OF PATIENTS WITH CYSTIC FIBROSIS (CF) AGED ≥12 YEARS HETEROZYGOUS FOR F508DEL-CFTR AND A RESIDUAL FUNCTION MUTATION (F508DEL/RF) TREATED WITH THE CF TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATOR (CFTRM) TEZACA ...

    Oct 1, 2018, 00:00

  • PMS107 - THE EFFICACY OF ACTIVE STRETCHING TECHNIQUE AMONG PATIENTS WITH TYPE II DIABETES MELLITUS

    Oct 1, 2018, 00:00

  • PUK13 - THE TREATMENT OF IRON DEFICIENCY/ANAEMIA IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE IN GERMANY – A CLAIMS DATABASE ANALYSIS

    Oct 1, 2018, 00:00

  • PCV149 - A SYSTEMATIC LITERATURE REVIEW (SLR) OF HEALTH STATE UTILITIES ASSOCIATED WITH NON-FATAL MYOCARDIAL INFARCTION (MI) OR ACUTE CORONARY SYNDROME (ACS)

    Oct 1, 2018, 00:00

  • PMH69 - QUALITY OF LIFE ACCORDING TO RESPONDER RATE IN OPIOID DEPENDENT ADULTS RECEIVING TREATMENT WITH BUPRENORPHINE DEPOT INJECTIONS (CAM2038) VERSUS SUBLINGUAL BUPRENORPHINE/NALOXONE

    Oct 1, 2018, 00:00

  • PIH4 - HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH EXTREMELY PRETERM BIRTH IN THE NETHERLANDS

    Oct 1, 2018, 00:00

  • PRM216 - AGREEMENT BETWEEN REVISED BRUNET-LÉZINE AND INTERGROWTH-21ST NEURODEVELOPMENTAL ASSESSMENTS

    Oct 1, 2018, 00:00

  • PMU120 - ASSESSING THE RISK FACTORS OF COMPLICATIONS RELATED TO PERIPHERAL INTRAVENOUS CANNULAS

    Oct 1, 2018, 00:00

  • CV3 - COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN GERMANY- APPLYING THE EFFICIENCY THRESHOLD

    Oct 1, 2018, 00:00

  • PMD106 - COST-EFFECTIVENESS OF LONG-LASTING INSECTICIDE-NETS FOR THE PREVENTION OF MALARIA IN RURAL AND URBAN MALARIOUS AREAS

    Oct 1, 2018, 00:00

  • PMD180 - THE VALUE TO WOMEN WITH OVARIAN CANCER OF GENE VARIANTS WITH KNOWN AND UNKNOWN SIGNIFICANCE- A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2018, 00:00

  • PDB90 - ASSOCIATION BETWEEN SULFONYLUREA (SU) TREATMENT AND TRAFFIC ACCIDENTS IN DENMARK

    Oct 1, 2018, 00:00

  • PIN62 - COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINES IN A COHORT OF NEWBORNS IN COLOMBIA

    Oct 1, 2018, 00:00

  • PMS80 - PSORIATIC ARTHRITIS PREVALENCE IN PSORITIC PATIENTS- BRAZIL, CHILE AND COLOMBIA CASES

    Oct 1, 2018, 00:00

  • PMD152 - HEALTHCARE RESOURCE UTILIZATION, COMPLICATIONS AND COSTS FOR OPEN REDUCTION INTERNAL FIXATION OF THE FEMUR, TIBIA AND FIBULA

    Oct 1, 2018, 00:00

  • PCV56 - CLINICAL AND ECONOMIC BURDEN OF CARDIOVASCULAR DISEASE AND VALUE OF EVOLOCUMAB TREATMENT IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN SWEDEN

    Oct 1, 2018, 00:00

  • PSY212 - TREATMENT CHARACTERISTICS, QUALITY OF LIFE AND SLEEP PERFORMANCE OF LOCALISED NEUROPATHIC PAIN PATIENTS IN THE PRIMARY CARE SETTING

    Oct 1, 2018, 00:00

  • PCV78 - PHARMACOECONOMIC EVALUATION OF DIFFERENT DRUG TREATMENT ALTERNATIVES FOR HYPERTENSIVE PATIENTS AT A TERTIARY CARE HOSPITAL, BANGALORE, INDIA

    Oct 1, 2018, 00:00

  • PCN149 - COST-EFFECTIVENESS OF BRCA1/2 MUTATION PROFILING TO TARGET OLAPARIB USE IN PATIENTS WITH METASTATIC BREAST CANCER IN JAPAN

    Oct 1, 2018, 00:00

  • HT6 - DO SPAIN AND PORTUGAL EVALUATORS AND DECISION MAKERS GIVE THE SAME IMPORTANCE TO EVALUATION CRITERIA OF INNOVATIVE MEDICINES?

    Oct 1, 2018, 00:00

  • PSY177 - HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH BETA-THALASSEMIA

    Oct 1, 2018, 00:00

  • PRM254 - ON SIMULATION OF TIME TO PROGRESSION AND DEATH BASED ON AGGREGATE PFS AND OS CURVES

    Oct 1, 2018, 00:00

  • PDB101 - THERAPY ADJUSTMENT IN ADULT T2DM PATIENTS WITH RENAL IMPAIRMENT TREATED WITH DPP-4 INHIBITORS IN THE UK- A RETROSPECTIVE COHORT STUDY

    Oct 1, 2018, 00:00

  • PCN34 - PEMBROLIZUMAB PLUS CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NSCLC – A NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PMH30 - MENTAL DISORDERS AND MAJOR DEPRESSION- THE ECONOMIC ANALYSIS OF SOCIAL SECURITY COSTS IN ITALY

    Oct 1, 2018, 00:00

  • PMD184 - PO-SCORAD TOOL IN BLACK SKIN PATIENTS WITH ATOPIC DERMATITIS- CORRELATION WITH THE SCORAD

    Oct 1, 2018, 00:00

  • PCP56 - EARLY ACCESS PROGRAMS- RECOMMENDATIONS FOR REAL-WORLD DATA COLLECTION

    Oct 1, 2018, 00:00

  • PSS65 - DEVELOPMENT OF THE NEUROTROPHIC KERATOPATHY QUESTIONNAIRE- QUALITATIVE RESEARCH

    Oct 1, 2018, 00:00

  • PSY36 - CLINICAL BURDEN OF CHRONIC GRAFT VERSUS HOST DISEASE- A SYSTEMATIC LITERATURE REVIEW OF INCIDENCE AND DISEASE SEVERITY

    Oct 1, 2018, 00:00

  • PIN63 - A COST-MINIMIZATION MODEL TO EVALUATE THE IMPACT OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS IN HOSPITALIZED ADULTS IN SPAIN

    Oct 1, 2018, 00:00

  • PMU105 - PATIENT PREFERENCES IN HEALTH TECHNOLOGY ASSESSMENT- A SYSTEMATIC REVIEW AND RESEARCH AGENDA

    Oct 1, 2018, 00:00

  • PMU33 - ESTIMATING THE COST OF A CAESAREAN SECTION IN A PUBLIC HOSPITAL IN CYPRUS

    Oct 1, 2018, 00:00

  • PMD119 - SYSTEMATIC REVIEW ON CLINICAL OUTCOMES OF ULTRASONIC TECHNOLOGY FOR PATIENTS UNDERGOING COLORECTAL ONCOLOGY PROCEDURES

    Oct 1, 2018, 00:00

  • PMD75 - THE COST-EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION- EXPLORING THE ITALIAN NATIONAL HEALTH SYSTEM PERSPECTIVE AND CONSIDERING DIFFERENT PATIENTS RISK GROUPS

    Oct 1, 2018, 00:00

  • PMS84 - COMPARISON OF HTA ASSESSMENTS OF SARILUMAB IN DIFFERENT SUBPOPULATIONS FOR RHEUMATOID ARTHRITIS

    Oct 1, 2018, 00:00

  • PHP171 - REVISITING REIMBURSED DRUGS WITH ALTERNATIVE PAYMENT MODEL IN TURKEY- 2016-2018

    Oct 1, 2018, 00:00

  • PHP211 - ESTIMATION OF PHARMACEUTICAL CARE SERVICES IN UKRAINE- ISSUES AND WAYS FOR IMPROVEMENT

    Oct 1, 2018, 00:00

  • PSY33 - FEASIBILITY OF EVALUATING THE BURDEN OF B-THALASSEMIA WITH GERMAN CLAIMS DATA

    Oct 1, 2018, 00:00

  • PIN47 - THE POTENTIAL ROLE OF COST-EFFECTIVENESS ANALYSIS AND INCREMENTAL COST-EFFECTIVENESS RATIO THRESHOLDS IN THE UNITED STATES CENTERS FOR DISEASE CONTROL AND PREVENTION’S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (CDC ACIP) VACCINAT ...

    Oct 1, 2018, 00:00

  • PRM126 - A COMPARISON OF MIXTURE CURE AND STANDARD PARAMETRIC MODELING TO ESTIMATE LONG-TERM SURVIVAL FOR SMALL-CELL LUNG CANCER IN PATIENTS TREATED WITH NIVOLUMAB AFTER PROGRESSION

    Oct 1, 2018, 00:00

  • PND57 - THE COST-EFFECTIVENESS OF ALEMTUZUMAB IN THE MANAGEMENT OF RELAPSE-REMITTING MULTIPLE SCLEROSIS IN ITALY

    Oct 1, 2018, 00:00

  • PCN140 - COST-EFFECTIVENESS ANALYSIS OF ALECTINIB VS CRIZOTINIB IN FIRST LINE ANAPLASTIC LYMPHOMA KINASE POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER IN PORTUGAL

    Oct 1, 2018, 00:00

  • PND98 - DETERMINING THE VALUE OF OCREVUS® (OCRELIZUMAB) FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

    Oct 1, 2018, 00:00

  • PIN20 - A COST-EFFECTIVENESS ANALYSIS OF THE INFLUENZA VACCINE IN ADULT PATIENTS WITH CANCER

    Oct 1, 2018, 00:00

  • PRS20 - HEALTH PLAN COVERAGE OF SMOKING CESSATION TREATMENT WITH DRUG THERAPY IS COST-EFFECTIVE? A HEALTHCARE PAYER PERSPECTIVE IN BRAZIL

    Oct 1, 2018, 00:00

  • PRS74 - ANTI-PNEUMOCOCCAL VACCINATION STRATEGY. STUDY AND PRELIMINARY RWD DECREASING GERIATRICS HOSPITAL ADMISSIONS AND CARE COSTS

    Oct 1, 2018, 00:00

  • PMD49 - COST ANALYSIS OF USING THREE-DIMENSIONAL COMPLEX MAPPING CATHETER ABLATION VERSUS DRUG THERAPY FOR THE TREATMENT OF ATRIAL FIBRILLATION IN TURKEY

    Oct 1, 2018, 00:00

  • PRS89 - MEASUREMENT OF MAINTENANCE AND RELIEVER USE IN ASTHMA- A SYSTEMATIC REVIEW OF THE LITERATURE

    Oct 1, 2018, 00:00

  • PCP3 - ADAPTIVE PATHWAYS 2020- WHAT’S ON THE HORIZON IN THE NEXT 2-3 YEARS?

    Oct 1, 2018, 00:00

  • PCV126 - A COST-EFFECTIVENESS THRESHOLD BASED ON THE MARGINAL RETURNS OF CARDIOVASCULAR HOSPITAL SPENDING

    Oct 1, 2018, 00:00

  • PCN69 - BUDGET IMPACT OF SUBSTITUTING BIOSIMILAR TRASTUZUMAB (CT-P6) IN TREATING GASTRIC CANCER AND BREAST CANCER IN 28 EUROPEAN COUNTRIES

    Oct 1, 2018, 00:00

  • PHP209 - FUNDING OF CLINICAL TRIALS IN UNIVERSITY HOSPITAL ENVIRONMENT

    Oct 1, 2018, 00:00

  • PMD51 - COMPARISON OF COSTS AND OUTCOMES BETWEEN COBLATION TECHNOLOGY AND ELECTROCAUTERY FOLLOWING TONSILLECTOMY AND ADENOIDECTOMY PROCEDURES

    Oct 1, 2018, 00:00

  • PCN117 - HEALTHCARE EXPENDITURES FOR THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA IN JAPAN

    Oct 1, 2018, 00:00

  • PMS6 - EFFECTIVENESS OF BIOSSIMILARS UNDER HOSPITAL PHARMACY MANAGEMENT POLICY

    Oct 1, 2018, 00:00

  • AD2 - A FULLY INTEGRATED CLINICAL TRIAL LIKE SYSTEM TO GUARANTEE PERSISTENCE ON PLANNED HEPATITIS C TREATMENT- EVIDENCE FROM THE REAL-WORLD

    Oct 1, 2018, 00:00

  • PHP319 - MANDATORY JOINT CLINICAL ASSESSMENT – WHAT IS THE ADDITIONAL INSIGHT FROM EU-NETHTA VS. EMA?

    Oct 1, 2018, 00:00

  • PMH25 - EARLY ADMINISTRATION OF ARIPIPRAZOLE LONG-ACTING INJECTABLE IN ACUTE INPATIENTS WITH SCHIZOPHRENIA REDUCES THE COST OF HOSPITALIZATION

    Oct 1, 2018, 00:00

  • ND2 - FUNCTIONAL LOSS ACROSS STAGES OF ALZHEIMER’S

    Oct 1, 2018, 00:00

  • PRM72 - PERFORMANCE OF AUTOMATED SCREENING OF CITATIONS COMPARED TO HUMAN REVIEWERS IN SYSTEMATIC LITERATURE REVIEWS- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PRM201 - PRESCRIPTION, ILLICIT AND HOMEOPATHIC DRUGS - ISSUES FACED IN LANGUAGE AND CULTURAL RELEVANCE WHEN REFERRING TO MEDICATION IN COAS.

    Oct 1, 2018, 00:00

  • PCN289 - HOW ACCELARATED IS PATIENTS’ ACCESS TO NEW ONCOLOGY PRODUCTS IN THE NEW ERA OF CANCER DRUG’S FUND IN ENGLAND?

    Oct 1, 2018, 00:00

  • PDB113 - PSYCHOMETRIC EVALUATION OF A SELF-REPORTED MEDICATION ADHERENCE MEASURE ADAPTED TO COMMUNITY PHARMACY PRACTICE - THE QUESTIONNAIRE ” TOP SCORE "

    Oct 1, 2018, 00:00

  • PSY209 - PATIENT NEEDS, PERCEPTIONS AND ATTITUDINAL DRIVERS ASSOCIATED WITH OBESITY- A QUALITATIVE ONLINE BULLETIN BOARD STUDY

    Oct 1, 2018, 00:00

  • PIH7 - LONG-ACTING RECOMBINANT FSH (CORIFOLLITROPIN ALFA) VERSUS RECOMBINANT FSH AS ASSISTED REPRODUCTION TECHNIQUES IN THE MANAGEMENT OF INFERTILITY- A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2018, 00:00

  • PDB118 - SYSTEMATIC EDUCATION IN PATIENTS WITH T2DM SIGNIFICANTLY IMPROVES ADHERENCE TO THE TREATMENT. THE ADVICE STUDY

    Oct 1, 2018, 00:00

  • PUK23 - EVALUATION OF THE PROGRAM OF NEPHROPROTECTION IN PATIENTS WITH RENAL DISEASE OF A COLOMBIAN INSURANCE COMPANY

    Oct 1, 2018, 00:00

  • PRM183 - DEVELOPMENT OF A FIT-FOR-PURPOSE TOBACCO AND NICOTINE PRODUCTS DEPENDENCE INSTRUMENT

    Oct 1, 2018, 00:00

  • PND54 - A LONG TERM ANALYSIS OF THE CLINICAL AND COST EFFECTIVENESS OF GLATIRAMER ACETATE USING FINAL 10-YEAR RESULTS FROM THE UK MULTIPLE SCLEROSIS RISK SHARING SCHEME

    Oct 1, 2018, 00:00

  • PMS82 - HOW DO HEALTH SYSTEM EMPLOYEES WITH ESTABLISHED MUSCULOSKELETAL COMPLAINTS DECIDE ON THEIR TREATMENT PATHWAY? A QUALITATIVE APPROACH

    Oct 1, 2018, 00:00

  • PRM202 - COMPARING THE EQ-5D-5L CROSSWALKS AND VALUE SETS FOR ENGLAND, THE NETHERLANDS AND SPAIN- DO CONCLUSIONS CHANGE?

    Oct 1, 2018, 00:00

  • CN1 - VALIDATING SURVIVAL EXTRAPOLATIONS IN FIRST LINE TREATMENT OF RENAL CELL CARCINOMA USING LITERATURE-BASED CONDITIONAL SURVIVAL PROBABILITIES

    Oct 1, 2018, 00:00

  • PRM263 - THE USE OF PRISMA STATEMENT IMPROVES THE REPORTING QUALITY OF META-ANALYSES PUBLISHED IN THE FIELD OF PSYCHOLOGY

    Oct 1, 2018, 00:00

  • PHP143 - ECONOMIC EVALUATIONS AND BUDGET IMPACT ANALYSES OF INNOVATIVE MEDICINES ACCORDING TO THE CATALAN HEALTH SERVICE STANDARDS- A QUALITATIVE ASSESSMENT

    Oct 1, 2018, 00:00

  • PMU65 - COST-MINIMIZATION ANALYSIS OF SMOFKABIVEN® CENTRAL FOR ADULT PATIENTS WITH IMPOSSIBLE, INSUFFICIENT OR CONTRAINDICATED ORAL OR ENTERAL NUTRITION VERSUS STANDARD ENDOVASCULAR TREATMENT IN THE MEXICAN PUBLIC HEALTHCARE SYSTEM

    Oct 1, 2018, 00:00

  • PHP14 - CO-CREATION OF PATIENT ENGAGEMENT QUALITY GUIDANCE AND QUALITY CRITERIA FOR MEDICINES DEVELOPMENT- AN INTERNATIONAL MULTI-STAKEHOLDER INITIATIVE

    Oct 1, 2018, 00:00

  • PSS64 - A PREFERENCE STUDY INVESTIGATING PATIENT CHOICE FOR TREATING SEVERE CHRONIC SPONTANTEOUS/IDIOPATHIC URTICARIA (CSU/CIU)

    Oct 1, 2018, 00:00

  • PSY37 - SYSTEMATIC LITERATURE REVIEW ON THE WORLDWIDE EPIDEMIOLOGY OF PROPIONIC ACIDEMIA

    Oct 1, 2018, 00:00

  • PMD21 - PRESSURE INJURIES IN PATIENTS WITH URINARY INCONTINENCE- EFFICACY OF REGENERA, A NEW MEDICAL DEVICE TESTED AT THE OSPEDALE MAGGIORE IN NOVARA

    Oct 1, 2018, 00:00

  • PHP25 - MENTAL HEALTH COMORBIDITIES AND ELEVATED RISK OF OPIOID USE IN ELDERLY BREAST CANCER SURVIVORS USING ADJUVANT ENDOCRINE TREATMENTS

    Oct 1, 2018, 00:00

  • PHP107 - THE STRUCTURE OF CONSUMPTION OF ANTIMICROBIAL DRUG FOR SYSTEMIC USE IN MULTIDISCIPLINARY HOSPITALS IN ST.PETERSBURG IN 2014-2015

    Oct 1, 2018, 00:00

  • PMS72 - ASSOCIATION BETWEEN HIGH CONCENTRATION NON-AVIAN HIGH MOLECULAR WEIGHT HYALURONAN AND TIME-TO-TOTAL KNEE REPLACEMENT SURGERY AMONG COMMERCIALLY-INSURED PATIENTS WITH KNEE OSTEOARTHRITIS IN THE UNITED STATES- A RETROSPECTIVE STUDY WI ...

    Oct 1, 2018, 00:00

  • AD3 - EVALUATION OF THE “SOPHIA” ASTHMA PATIENT MANAGEMENT PROGRAM AT TWO YEARS

    Oct 1, 2018, 00:00

  • PCN298 - MANAGEMENT OF ANTIEMETIC TREATMENT FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV)- PATIENTS’, ONCOLOGISTS’ AND NURSES’ PERSPECTIVES

    Oct 1, 2018, 00:00

  • PCV25 - LIPID MODIFYING THERAPY AND LDL-C ACHIEVEMENTS IN A VERY HIGH CARDIOVASCULAR RISK COHORT OF STATIN INTOLERANT PATIENTS MANAGED BY GENERAL PRACTITIONERS IN ITALY

    Oct 1, 2018, 00:00

  • PCN283 - IDENTIFYING THE KEY CHALLENGES AFFECTING THE REIMBURSEMENT OF CAR-T THERAPIES IN THE EU5 USING A WEB-BASED PORTAL TO ENGAGE PAYERS

    Oct 1, 2018, 00:00

  • PCN308 - DO HEALTH TECHNOLOGY APPRAISALS HAVE AN IMPACT?- A COMPARISON OF CENTRALIZED AND REGIONAL APPROACHES

    Oct 1, 2018, 00:00

  • PHP65 - ANALYSIS OF ICER-ESTIMATED VALUE-BASED PRICES AND POTENTIAL DISCOUNTS FOR DRUGS IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PRM194 - INVESTIGATING THE RELATIONSHIP BETWEEN AGE AND EXPANDED DISABILITY STATUS SCALE SCORE IN UNTREATED AND CHENODEOXYCHOLIC ACID-TREATED CEREBROTENDINOUS XANTHOMATOSIS PATIENTS

    Oct 1, 2018, 00:00

  • PRM199 - STAKEHOLDER PERSPECTIVES ON CONDUCT AND USE OF PATIENT PREFERENCE STUDIES ALONG THE MEDICAL PRODUCT LIFECYCLE- RESULTS FROM FOCUS GROUPS

    Oct 1, 2018, 00:00

  • PCN276 - MANAGED ACCESS AGREEMENTS UNDER THE CANCER DRUGS FUND (CDF)- KEY METRICS AND DRIVERS

    Oct 1, 2018, 00:00

  • PMU29 - EVALUATING BUDGET IMPACT ANALYSES FOR EXTRAMURAL DRUGS IN THE NETHERLANDS

    Oct 1, 2018, 00:00

  • PSY65 - REAL-WORLD DATA ANALYSIS OF US CLAIMS DATA ON COAGULATION FACTOR IX DISPENSATION AND EXPENDITURES IN PATIENTS WITH SEVERE HEMOPHILIA B- STANDARD HALF-LIFE VS. EXTENDED HALF-LIFE PRODUCTS

    Oct 1, 2018, 00:00

  • PSY158 - A PRAGMATIC LITERATURE REVIEW TO IDENTIFY ECONOMIC OUTCOMES FOR REPURPOSED DRUGS IN RARE DISEASES

    Oct 1, 2018, 00:00

  • PHP7 - DIGITALIZATION AND CUSTOMER-RESPONSIVE SECONDARY CARE SERVICES POTENTIALLY FREE HEALTH CARE CAPACITY- PREDICTED MONETARY BENEFITS OF VIRTUAL HOSPITAL 2.0

    Oct 1, 2018, 00:00

  • PCN339 - SPEAR-BLADDER (STUDY INFORMING TREATMENT PATHWAY DECISION IN BLADDER CANCER)- TIMING OF TREATMENT FOLLOWING FIRST-LINE THERAPY IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC UROTHELIAL CANCER IN THE COMMUNITY ONCOLOGY SETTING IN ...

    Oct 1, 2018, 00:00

  • PMD142 - WHAT DISCOURAGES ELDERLY USE OF INSULIN-INFUSION PUMPS IN JAPAN?

    Oct 1, 2018, 00:00

  • PMD94 - ECONOMIC EVALUATION OF ACCU-CHEK ® INSTANT S GLUCOMETER FOR THE SELF-MONITORING GLUCOSE (SMG) IN PATIENTS WITH DIABETES MELLITUS (DM), FROM THE VIEW OF THE PUBLIC HEALTHCARE SYSTEM IN MEXICO.

    Oct 1, 2018, 00:00

  • PMS37 - INDIRECT COSTS OF VERTEBRAL ALGIC SYNDROME

    Oct 1, 2018, 00:00

  • PCP36 - IMPROVING THE QUALITY OF MEDICAL CARE IN HYPERTENSIVE DISORDERS DURING PREGNANCY

    Oct 1, 2018, 00:00

  • PUK9 - NETWORK META-ANALYSIS OF TREATMENTS IN PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL-CELL CARCINOMA WITH INTERMEDIATE TO POOR PROGNOSIS

    Oct 1, 2018, 00:00

  • PSS49 - EPIDEMIOLOGY AND TREATMENT PATTERNS IN ADULT PATIENTS WITH ATOPIC DERMATITIS- ANALYSIS OF LONGITUDINAL DATA FROM THE GERMAN STATUTORY HEALTH INSURANCE SYSTEM

    Oct 1, 2018, 00:00

  • PRS2 - HEALTH OUTCOMES OF MATERNAL SMOKING DURING PREGNANCY AND POSTPARTUM PERIOD FOR THE MOTHER AND INFANT- AN UMBRELLA REVIEW

    Oct 1, 2018, 00:00

  • PRM192 - TYPE 2 DIABETES MELLITUS- LACK OF GOOD PRACTICES FOR REAL-WORLD EVIDENCE STUDIES.

    Oct 1, 2018, 00:00

  • PCN386 - QUALITY OF LIFE OF CAREGIVERS OF CANCER PATIENTS BEFORE AND AFTER PATIENT ADMISSION TO AN INTENSIVE CARE UNIT

    Oct 1, 2018, 00:00

  • PSY160 - REAL WORLD TREATMENT PATTERNS AND RESOURCE UTILIZATION IN PULMONARY ARTERIAL HYPERTENSION IN BRAZIL- A PUBLIC HEALTHCARE DATABASE STUDY

    Oct 1, 2018, 00:00

  • PMU30 - BUDGET AND HEALTH IMPACT OF IMMUNO-ONCOLOGY TREATMENTS IN ITALY

    Oct 1, 2018, 00:00

  • PMU81 - PHYSICIANS' PREFERENCES WITH RESPECT TO ADHERENCE PROGRAMS- A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2018, 00:00

  • PSS45 - A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.

    Oct 1, 2018, 00:00

  • AD1 - ASSOCIATION OF ADHERENCE AND TREATMENT INTENSITY WITH CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ATHEROSCLEROSIS OR OTHER CARDIOVASCULAR RISK FACTORS TREATED WITH STATINS AND/OR EZETIMIBE

    Oct 1, 2018, 00:00

  • PCN37 - MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF APALUTAMIDE AND ENZALUTAMIDE IN THE TREATMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

    Oct 1, 2018, 00:00

  • PMU66 - COST-EFFECTIVENESS ANALYSIS OF IXEKIZUMAB VERSUS SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND CONCOMITANT MODERATE-TO-SEVERE PSORIASIS IN SPAIN

    Oct 1, 2018, 00:00

  • PND121 - UTILITIES ASSOCIATED WITH ATTRIBUTES OF MIGRAINE PREVENTIVE TREATMENTS- ROUTE OF ADMINISTRATION AND ADVERSE EVENTS

    Oct 1, 2018, 00:00

  • PMH45 - MODELLING THE BUDGETARY IMPACT OF TREATING OPIOID ADDICTION IN THE ENGLISH MUNICIPAL SETTING

    Oct 1, 2018, 00:00

  • PGI45 - RELIABILITY AND VALIDITY OF A NEW PATIENT-REPORTED OUTCOME FOR GASTROPARESIS

    Oct 1, 2018, 00:00

  • PND136 - FUNCTIONAL, EMOTIONAL AND SOCIAL IMPACT OF MIGRAINE IN PORTUGAL

    Oct 1, 2018, 00:00

  • PMD10 - PREVALENCE OF UNCONTROLLED BLOOD PRESSURE AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS

    Oct 1, 2018, 00:00

  • PIN79 - ECONOMIC CONSEQUENCES OF ANTI-HCV ANTIVIRAL TREATMENT INVESTMENT FROM THE NHS PERSPECTIVE- A REAL-WORLD-BASED ANALYSIS FROM PITER DATA

    Oct 1, 2018, 00:00

  • PHP195 - DO COMPANIES’ MARKET ACCESS TRAINING CAPABILITIES ADDRESS THE NEEDS OF TODAY’S COMPLEX PAYER MARKETPLACE?

    Oct 1, 2018, 00:00

  • PRM168 - FLUFFY, SOFT OR HARD LIKE NUTS; PASSING POO EASILY AROUND THE WORLD - CHALLENGES IN TRANSLATING THE CROHN’S DISEASE QUESTIONNAIRE INTO 80 LANGUAGES

    Oct 1, 2018, 00:00

  • PHP310 - COMPARISON OF THE HEALTH TECHNOLOGY ASSESSMENT OFFICES OF HUNGARY AND POLAND BASED ON OBJECTIVE CRITERIA

    Oct 1, 2018, 00:00

  • PGI52 - DECREASED WORK PRODUCTIVITY AND INCREASED HEALTHCARE RESOURCE UTILISATION (HRU) AMONG PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) – RESULTS FROM A REAL WORLD EVIDENCE STUDY

    Oct 1, 2018, 00:00

  • PND13 - REAL WORLD EVIDENCE (RWE) ON IMPACT OF AGE ON LONG-TERM PERSISTENCE TO DISEASE MODIFYING THERAPIES (DMTS) IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN AUSTRALIA

    Oct 1, 2018, 00:00

  • PCN174 - NEPA, AN ORAL FIXED COMBINATION OF NETUPITANT AND PALONOSETRON, IS A COST-EFFECTIVE INTERVENTION FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN GERMANY AND GREECE

    Oct 1, 2018, 00:00

  • PGI34 - A COST SAVING MEASURE FROM THE UTILISATION OF BIOSIMILAR INFLIXIMAB IN THE IRISH SECONDARY CARE SETTING

    Oct 1, 2018, 00:00

  • PSY69 - THE BURDEN OF HYPERKALEMIA IN GERMANY – A CLAIMS DATABASE ANALYSIS

    Oct 1, 2018, 00:00

  • PHP365 - TRENDS AND CHARACTERISTICS OF MANAGED ACCESS AGREEMENTS APPROVED BY NICE

    Oct 1, 2018, 00:00

  • PHP217 - TIME TO MARKET AND PRICE COMPARISON FOR BIOSIMILAR DRUGS IN EU5

    Oct 1, 2018, 00:00

  • PND47 - ECONOMIC BURDEN OF ALZHEIMER’S DISEASE IN THE UK

    Oct 1, 2018, 00:00

  • PHP56 - EARLY ACCESS PROGRAMS- AN ANALYSIS SINCE THEIR ESTABLISHMENT IN ITALY

    Oct 1, 2018, 00:00

  • PMS106 - COMPARISON OF DYNAMIC AND STATIC BALANCE AMONG HUNGARIAN AND FINNISH ADOLESCENT FOOTBALL PLAYERS

    Oct 1, 2018, 00:00

  • PRM131 - HEPATITIS C VIRUS ELIMINATION AND ERADICATION MODELS- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PRM262 - TRENDS IN DRUG PRICES BEFORE AND AFTER GENERIC COMPETITION IN THE US (2014-2016)

    Oct 1, 2018, 00:00

  • PHP316 - EXPLORING BIOSIMILAR MARKET ACCESS CONSIDERATIONS ACROSS THE EU

    Oct 1, 2018, 00:00

  • PSY176 - SIGNIFICANT BENEFIT AND RELATIVE EFFECTIVENESS ASSESSMENT OF ORPHAN MEDICINAL PRODUCTS IN THE EUROPEAN UNION- A COMPARATIVE ANALYSIS

    Oct 1, 2018, 00:00

  • PRM164 - THREE STATE MARKOV MODEL INVESTIGATING THE PROGRESSION OF BREAST CANCER

    Oct 1, 2018, 00:00

  • PCN10 - ECONOMIC IMPACT OF MEDICATION ERRORS DETECTED IN ONCOLOGIC INPATIENTS AND OUTPATIENTS IN A MEXICAN HOSPITAL

    Oct 1, 2018, 00:00

  • PSS37 - A SYSTEMATIC REVIEW OF THE METHODOLOGICAL QUALITY OF ECONOMIC STUDIES EVALUATING OPHTHALMIC DRUGS

    Oct 1, 2018, 00:00

  • PHP67 - CURRENT INITIATIVES FUTURE OF E-HEALTH FUNDING PATHS

    Oct 1, 2018, 00:00

  • PCN345 - HEALTH STATE UTILITIES IN METASTATIC NSCLC- A STUDY OF MULTIPLE IMMUNO-ONCOLOGY TRIALS

    Oct 1, 2018, 00:00

  • PSY135 - ACCESS TO ORPHAN DRUGS – REGULATION WITHIN THE EUROPEAN LAW

    Oct 1, 2018, 00:00

  • PIH48 - CAN OLDER USERS USE ELECTRONIC CLINICAL OUTCOME ASSESSMENTS (ECOA)?

    Oct 1, 2018, 00:00

  • PHP5 - DEVELOPMENT OF THE PATIENT ORGANISATION SUBMISSION PROCESS IN THE NATIONAL CENTRE FOR PHARMACOECONOMICS (NCPE), IRELAND

    Oct 1, 2018, 00:00

  • PRM143 - EXPLORING THE EFFECTS OF SUBSEQUENT LIFE EXTENDING TREATMENTS ON CANCER TRIAL ENPOINTS USING CLINICAL TRIAL SIMULATION

    Oct 1, 2018, 00:00

  • PMU125 - EVALUATING THE INFLUENCE OF SHARED DECISION-MAKING ON PATIENTS' HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE GENERAL-OUTPATIENT CLINIC IN HONG KONG SAR, CHINA

    Oct 1, 2018, 00:00

  • PHP197 - AN EVALUATION OF THE PERFORMANCE OF HOSPITAL PHARMACIES’ GROUP PURCHASING ORGANIZATION TO PROMOTE HEALTHCARE MANAGEMENT

    Oct 1, 2018, 00:00

  • PGI44 - PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) REPORT POSITIVE EXPERIENCE AFTER PARTICIPATING IN AN ONLINE QUANTITATIVE PREFERENCE SURVEY

    Oct 1, 2018, 00:00

  • PCV104 - BETA-BLOCKERS, ANGIOTENSIN II, AND ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN PATIENTS WITH HEART FAILURE. DIFFERENCES IN PRESCRIPTION BY GENDER, SOCIOECONOMIC STATUS AND COMORBIDITY AFTER A FIRST HOSPITALIZATION FOR HEART FAILURE ...

    Oct 1, 2018, 00:00

  • PRM229 - THE CLUSTERED NATURE OF TRIAL-BASED ECONOMIC EVALUATIONS- DOES IT MATTER?

    Oct 1, 2018, 00:00

  • PRS32 - IMPACT OF SEVERE ASTHMA IN FRANCE- A CLAIM DATABASE STUDY

    Oct 1, 2018, 00:00

  • PGI29 - GENDER DIFFERENCES IN CLINICAL PROFILE AND HEALTHCARE UTILIZATION OF NON ALCOHOLIC FATTY LIVER PATIENTS

    Oct 1, 2018, 00:00

  • PRS70 - REAL-LIFE RETROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE AND ECONOMIC BURDEN OF SEVERE ASTHMA

    Oct 1, 2018, 00:00

  • PHP112 - DO PATIENTS KNOW ABOUT THEIR CHRONIC HEALTH PROBLEMS AND THE DRUGS THEY TAKE?

    Oct 1, 2018, 00:00

  • PMH51 - HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG COMMUNITY-DWELLING SUBJECTS WITH SCHIZOPHRENIA TREATED WITH RBP-7000 IN A CLINICAL TRIAL SETTING OVER 12 MONTHS

    Oct 1, 2018, 00:00

  • PCN15 - INVESTIGATION OF THE ASSOCIATION BETWEEN INCIDENT METFORMIN EXPOSURE AND NON-SMALL CELL LUNG CANCER DIAGNOSIS AMONG DIABETIC PATIENTS

    Oct 1, 2018, 00:00

  • PSY201 - A SYSTEMATIC REVIEW OF DISCRETE CHOICE EXPERIMENTS IN HEMOPHILIA

    Oct 1, 2018, 00:00

  • PMD90 - ECONOMIC EVALUATION OF THE IMMUNOCYTOCHEMISTRY TEST FOR THE SIMULTANEOUS QUALITATIVE DETECTION OF PROTEINS P16INKA AND KI-67 (CINTEC PLUS CYTOLOGY KIT®) IN CERVICAL TISSUE

    Oct 1, 2018, 00:00

  • PMD39 - BUDGET IMPACT ANALYSIS TO TAKE DECISIONS ABOUT TIME OF INVESTMENT RECOVERY IN IMPLANTABLE MEDICAL DEVICES- TRABECULAR MICRO-BYPASS STENT IN OPEN-ANGLE GLAUCOMA

    Oct 1, 2018, 00:00

  • PMS25 - COST COMPARISON OF OPEN, MINIMALLY INVASIVE AND GUIDE-WIRELESS MINIMALLY INVASIVE SURGERY TRANSFORAMINAL LUMBAR INTERBODY FUSION (GMIS/TLIF) INTERVENTION FOR LUMBAR DEGENERATIVE DISC DISEASE IN THE UK

    Oct 1, 2018, 00:00

  • PHP79 - LESS HASTE, MORE SPEED? DO EUROPEAN ACCELERATED AUTHORISATIONS TRANSLATE INTO EARLY REIMBURSEMENT AND PATIENT ACCESS?

    Oct 1, 2018, 00:00

  • PCN335 - TIME TRENDS IN FRONTLINE SYSTEMIC THERAPY UTILIZATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PMU25 - EXAMINING THE CONSISTENCY AND ACCURACY OF THE BUDGET IMPACT MODELS SUBMITTED TO THE NATIONAL CENTRE FOR PHARMACOECONOMICS IN IRELAND TO AID THE CREATION OF AN APPLICANT TEMPLATE

    Oct 1, 2018, 00:00

  • PIH25 - BE AWARE OF PEDIATRIC MALNUTRITION AT ADMISSION! ECONOMIC CONSEQUENCES OF DIFFERENT HOSPITAL SCREENING AND NUTRITIONAL TREATMENT APPROACHES.

    Oct 1, 2018, 00:00

  • PHP222 - IDENTIFYING THE KEY DRIVERS AFFECTING THE REIMBURSEMENT OF THERAPEUTIC VACCINES IN EU5 COUNTRIES USING A WEB-BASED PORTAL TO ENGAGE PAYERS

    Oct 1, 2018, 00:00

  • PMD153 - TURKISH PUBLIC PROCUREMENT SYSTEM FOR MEDICAL DEVICES- IS THERE ROOM FOR IMPROVEMENT WHEN VALUING QUALITY?

    Oct 1, 2018, 00:00

  • PCP9 - GENE THERAPY CRISIS- HOW WILL THE CURRENT PRODUCT PIPELINE AFFECT THE PHARMACEUTICAL INDUSTRY AND HEALTHCARE SYSTEMS?

    Oct 1, 2018, 00:00

  • PGI26 - COST SAVING ANALYSIS OF A COMMUNITY STOMA CARE SERVICE

    Oct 1, 2018, 00:00

  • PCN181 - COST-UTILITY ANALYSIS OF ADJUVANT PERTUZUMAB-BASED REGIMEN IN WOMEN WITH HER2-POSITIVE BREAST CANCER IN ITALY

    Oct 1, 2018, 00:00

  • PRM88 - THE ADVANCEMENT OF TOOLS FOR AUTOMATING DATA EXTRACTION IN SYSTEMATIC REVIEWS

    Oct 1, 2018, 00:00

  • PMH16 - THE PRESCRIPTION PATTERNS OF SELECTIVE SEROTONIN (NOREPINEPHRINE) REUPTAKE INHIBITORS IN GERMANY

    Oct 1, 2018, 00:00

  • PHP355 - THE FUTURE OF VALUE-BASED CONTRACTING FOR HIGH-COST INNOVATIVE THERAPIES- GLOBAL LESSONS FROM EUROPE AND THE US

    Oct 1, 2018, 00:00

  • PHP32 - IMPACT OF MANUFACTURER COMPETITION ON PRESCRIPTION DRUG PRICE INFLATION IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PCN210 - USING REAL WORLD DATA TO DETERMINE HEALTH SYSTEM COSTS OF A 5-YEAR NON-SMALL CELL LUNG CANCER COHORT

    Oct 1, 2018, 00:00

  • PUK30 - THE BURDEN ASSOCIATED WITH COMPLEMENT 3 GLOMERULOPATHY (C3G)

    Oct 1, 2018, 00:00

  • PRM2 - IDENTIFICATION OF DOSE-ESCALATION IN BIOLOGIC THERAPY BASED ON CLAIMS DATA- THE EXAMPLE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

    Oct 1, 2018, 00:00

  • PMU11 - THE EFFECT OF FREQUENT FAMILY MEALTIMES ON CHILDREN AND ADOLESCENTS- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PIN93 - REAL-WORLD TIGECYCLINE USE IN CHINA FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS (CIAIS)

    Oct 1, 2018, 00:00

  • PRM158 - PREDICTIVE BIOMARKERS OF TREATMENT SUCCESS IN ADVANCED NON–SMALL CELL LUNG CANCER PATIENTS USING MULTIVARIATE CAUSAL INFERENCE.

    Oct 1, 2018, 00:00

  • PSS74 - PATIENT QUALITY OF LIFE AND SATISFACTION IN AN APREMILAST-TREATED PSORIASIS POPULATION- ANALYSIS OF 126 PATIENTS FROM THE APPRECIATE STUDY IN THE UNITED KINGDOM AND IRELAND

    Oct 1, 2018, 00:00

  • PRM46 - MEASURING AND ANALYSING THE MATURITY OF OVERALL SURVIVAL DATA FOR TREATMENTS FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA

    Oct 1, 2018, 00:00

  • PSY199 - WHAT ARE THE MOST VALUED PATIENT OUTCOMES REGARDING MEDICAL CARE FOR FRENCH PATIENTS WITH OBESITY? RESULTS FROM AN ONLINE PATIENT COMMUNITY (CARENITY.COM)

    Oct 1, 2018, 00:00

  • PCV15 - DRUGS FOR TREATING SEVERE HYPERTENSION IN PREGNANCY- A NETWORK META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS OF RANDOMIZED CLINICAL TRIALS

    Oct 1, 2018, 00:00

  • PSY118 - RESOURCE USE AMONG BIOLOGICAL THERAPY INITIATORS WITH CROHN’S DISEASE IN FINLAND

    Oct 1, 2018, 00:00

  • PND44 - A NEW APPROACH FOR ESTIMATING AND VISUALISING SOCIETAL COSTS- AN EXAMPLE IN MULTIPLE SCLEROSIS IN ENGLAND

    Oct 1, 2018, 00:00
  • «
  • 51
  • 52
  • 53
  • 54
  • 55 (current)
  • 56
  • 57
  • 58
  • 59
  • 60
  • »